Sentinel lymph node biopsy in head and neck cancer

Karen T. Pitman, Alfio Ferlito, Kenneth O. Devaney, Ashok R. Shaha, Alessandra Rinaldo

Research output: Contribution to journalReview articlepeer-review


In the past decade, the technique of sentinel lymph node biopsy (SLNB) has been applied to a vast array of primary neoplasms, ranging from head and neck melanoma to vulvar carcinoma. At present, experience with SLNB is greatest in patients with melanoma and breast cancer. In view of the well known complications associated with cervical node dissection, it has been suspected for some time that cervical SLNB, if successful, might reduce the morbidity associated with the definitive care of patients with head and neck cancers. This report assesses the current status of SLNB in the treatment of head and neck cancers; while formal investigations of the efficacy of this technique are recommended, SLNB has not yet been demonstrated to possess the same level of utility seen in SLNB in melanoma and breast cancer patients. As a consequence, the application of SLNB to head and neck cancers remains an experimental technique - one which has not yet acquired the status of the standard of patient care.

Original languageEnglish (US)
Pages (from-to)343-349
Number of pages7
JournalOral Oncology
Issue number4
StatePublished - Jun 2003
Externally publishedYes


  • Head and neck cancer
  • Sentinel lymph node biopsy

ASJC Scopus subject areas

  • Oral Surgery
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Sentinel lymph node biopsy in head and neck cancer'. Together they form a unique fingerprint.

Cite this